6.82
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
What drives Tango Therapeutics Inc. stock priceMassive portfolio appreciation - Autocar Professional
Is Tango Therapeutics Inc. a good long term investmentPhenomenal investment performance - PrintWeekIndia
Will Tango Therapeutics Inc. stock benefit from AI tech trendsSuperior capital gains - jammulinksnews.com
What analysts say about Tango Therapeutics Inc. stockExplosive portfolio gains - Autocar Professional
Tango Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com
Optimistic Investors Push Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Up 31% But Growth Is Lacking - 富途牛牛
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 - GlobeNewswire
Tango Therapeutics Earnings Alert: Q2 2025 Results Coming August 5 Without Investor Call - Stock Titan
Will Tango Therapeutics Inc. stock benefit from interest rate changesMarket Timing Advice - Newser
How Tango Therapeutics Inc. stock performs during market volatilityFree Consultation - Newser
How high can Tango Therapeutics Inc. stock price go in 2025Daily Volume Leaders - Newser
Can Tango Therapeutics Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect? - MSN
What makes Tango Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser
Why Tango Therapeutics Inc. stock attracts strong analyst attentionFree Capital Growth Strategies - Newser
Tango Therapeutics (TNGX) Soars 5.96% on Strong Q2 Earnings - AInvest
Tango Therapeutics’ SWOT analysis: biotech stock’s potential in precision cancer therapies - Investing.com
Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - MSN
HC Wainwright Issues Optimistic Forecast for TNGX Earnings - Defense World
Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 3000 Value Index - MarketScreener
H.C. Wainwright reiterates Buy rating on Tango Therapeutics stock - Investing.com
Tango Therapeutics Announces First Patient Dosed in Phase - GlobeNewswire
Tango Therapeutics Launches Groundbreaking Trial for Advanced Pancreatic and Lung Cancer Treatment - Stock Titan
Exchange Traded Concepts LLC Purchases 47,901 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):